INTRODUCTION
Cytosine methylation at the 5-carbon position (5-methylcytosine; 5mC) is a critical repressive epigenetic mark in the mammalian genome (Bird, 2002; Ma et al., 2010; Schubeler, 2015; Spivakov and Fisher, 2007) . 5mC is generally viewed as a stable and irreversible covalent modification to DNA; however, the fact that ten-eleven translocation (TET) proteins can oxidize 5mC to 5-hydroxymethylcytosine (5hmC) and downstream derivatives gives us a new perspective on the plasticity of 5mC-dependent regulatory processes (Zhang et al., 2012) . Cytosine modifications exist in bacteria, archaea, viruses, fungi, vertebrates, and plants, but their presence and functions remain controversial in model organisms such as Drosophila (Lyko et al., 2000; Zhang et al., 2015b) .
Surprisingly, a TET ortholog with unknown function exists in the fly genome (Dunwell et al., 2013) . Recent studies demonstrated that this Drosophila TET ortholog could demethylate the DNA modification N6-Methyladenine (6mA) in eukaryotes (Zhang et al., 2015b) , a prevalent DNA modification previously only found in bacteria. 6mA was also recently found in algae, worms, fungi and mammals (Fu et al., 2015; Greer et al., 2015; Koziol et al., 2016; Mondo et al., 2017; Wu et al., 2016; Zhang et al., 2015b) . Although this Drosophila TET ortholog was identified as a 6mA demethylase (DMAD) (Zhang et al., 2015b) , the precise molecular functions of 6mA and DMAD in Drosophila genome remain unknown.
RESULTS

DMAD depletion in Drosophila brain results in brain developmental defects accompanied by 6mA accumulation
Gene expression analyses across adult fly tissues show that DMAD is highly expressed in fly brains ( Figure 1A) . Previous work showed that DMAD is essential for development since only a small fraction of DMAD-null mutants can survive through the pupa stage, although these mutants die within 3 days post-eclosion (Zhang et al., 2015b) . To understand the role DMAD plays in fly brain function, we generated multiple transgenic lines, P{UASp-artimiR-DMAD}, which carry artificial miRNAs targeting DMAD. Consistent with DMADnull flies (Zhang et al., 2015b) , ubiquitous expression of artificial miRNAs against DMAD using the driver Tubulin-GAL4 (DMAD-KD) resulted in developmental defects, as most flies died pre-eclosion ( Figure S1A ). The mRNA of DMAD was effectively depleted in two DMAD-KD lines ( Figure S1B ). Neuronal-specific DMAD knockdown (DMAD-nKD) under the control of the pan-neuronal driver Elav-GAL4 resulted in mushroom body (MB) abnormalities in adult flies. MBs are one of the best-characterized brain regions involved in learning and memory in flies and are composed of axon-like fiber structures forming Fas IIpositive neuronal lobes (the a-, b-and g-lobes) ( Figure S1C) (Heisenberg, 2003) . In DMAD-nKD flies, the b-lobes, which normally end at the midline cleft, often crossed the midline. Also, DMAD-nKD flies also bore accessory MB phenotypes, such as missing or misdirected a-and b-lobes, as well as truncated or overbranched lobes ( Figure S1C ). These data suggest that DMAD may contribute to neuronal morphology, development, and function in the fly brain.
DMAD possesses enzymatic activity as a DNA N 6 -Methyladenine (6mA) demethylase in fly ovaries (Zhang et al., 2015b) . To confirm this enzymatic activity in fly brains, we applied the highly sensitive ultra-performance liquid chromatography tandem mass spectrometer (UHPLCMS/MS) to quantify 6mA and 5hmC abundance in control and DMAD-null fly brains (Schubeler, 2015; Zhang et al., 2015b) . The DMAD protein level was abolished entirely in DMAD-null fly brains ( Figure S1D ). Consistent with previous findings, a shallow level of 5hmC was detectable in control fly brains (Dunwell et al., 2013; Raddatz et al., 2013) , and DMAD depletion had minimal effects on 5hmC abundance (average 5hmC/C ppm increased from 2.29 to 3.44). In contrast to 5hmC, we detected higher levels of 6mA than 5hmC in control fly brains (average 26.0 6mA/A ppm). Importantly, 6mA levels significantly increased 4-fold in DMAD-null flies relative to controls ( Figure 1B and Table  S1 ). We confirmed this finding with dot blots using a 6mA-specific antibody ( Figure 1C ). To further confirm that DMAD is a 6mA demethylase in fly neuronal cells, we performed 6mA immunostaining in control and DMAD-nKD flies. Neuronal-specific DMAD knockdown using Elav-Gal4 resulted in 6mA accumulation explicitly in Elav-expressing neuronal cells ( Figure 1D ). Also, in vitro, 6mA demethylation assays using double-stranded synthetic oligonucleotide substrates indicated that recombinant DMAD demethylates 6mA ( Figure  S1E and S1F). These findings provide strong support for the role of DMAD as 6mA demethylase in fly brains. One recent study suggested that DMAD can generate 5hydroxymethylcytosine in RNA molecules (5hmrC), and DMAD-deficient S2 cells showed decreased 5hmrC (Delatte et al., 2016) . To test this, we applied UHPLC-MS/MS to precisely quantify the 5hmrC levels in control, DMAD-null fly brains, and DMAD-knockdown S2 cells. Extremely low levels of 5hmrC (0.2 ppm in fly brains and 2 ppm in S2 cells versus 25-100 ppm 6mA) were detected ( Figure S1G ), indicating 6mA is a major substrate for DMAD in Drosophila genome. No significant change in RNA 5mC was observed ( Figure   S1H ). Furthermore, we tested the 6mA levels in an AlkB neuronal knockdown, which is a homolog of mammalian 6mA putative demethylase Alkbh1 (Wu et al., 2016) . No substantial 6mA accumulation was found in the absence of AlkB ( Figure S1I ), suggesting DMAD could be the key 6mA demethylase in Drosophila. Since the key residues responsible for DMAD's demethylation activities were defined (Zhang et al., 2015b) , we generated the recombinant DMAD catalytic domain (DMADCD) and its catalytically dead mutations (DMAD-CDmut) to test their direct demethylation activity in vitro. The DMAD-CD has comparable demethylation activities with bacterial 6mA demethylase ALKB. In agreement with previous observations, the DMAD-CD-mutant displayed drastic and significant reduced enzymatic activity for 6mA demethylation ( Figure S1J ).
To understand the molecular functions of active 6mA demethylation, we generated genomewide 6mA maps from control and DMAD-null fly brains. We immunoprecipitated 6mAcontaining DNA isolated from ~1,000 dissected fly brains and used high-throughput sequencing to identify genomic loci enriched for 6mA. The specificity and reproducibility of 6mA immunoprecipitation were ensured using competitive elution with excess 6mA. Overall, the number of binned genomic regions containing high 6mA reads was larger in DMAD-null brains ( Figure S1K ). We identified 5340 high confidence gain-of-6mA regions in DMAD-null mutants relative to control flies. Thus, these regions represent active 6mA demethylation loci in wild-type brains ( Figure S1L and Table S1 ). Genomic annotation of gain-of-6mA regions revealed that a large percentage of 6mA increases occurred in intragenic regions, with enrichment in introns and untranslated regions (UTRs) compared to expected values. Consistent with previous observations (Zhang et al., 2015b) , gain-of-6mA regions were also enriched for several classes of repetitive elements relative to expected values ( Figure 1E ),.
To investigate the connection between dynamic 6mA demethylation and global transcriptome changes, we performed RNA-seq on control and DMAD-null fly brains (Table  S1 ). 1704 downregulated, and 1349 upregulated genes bearing significant accumulation of 6mA on their gene bodies upon DMAD depletion were found ( Figure 1F , purple and pink, respectively). Gene Ontology (GO) analysis of these downregulated genes showed enrichment in several key ontology terms reflecting DMAD-null fly phenotypes such as behavior, learning and memory, and neuronal differentiation ( Figure 1G ). In contrast, upregulated genes were enriched in general development-related functions ( Figure S1M ). To further investigate the potential regulatory mechanisms underlying 6mA-mediated gene regulation, we searched for common motifs within gain-of-6mA regions and predicted possible binding factors based on these motifs. Intriguingly, the 6mA motif "AGAAGGAG" in fly brains was previously found in C. elegans (Greer et al., 2015) , potentially suggesting a conserved mechanism of 6mA regulation across species. Several known DNA-binding proteins, such as transcription factors Aef1 and Adf1, were predicted to bind to these regions ( Figure S1N ). Interestingly, both Aef1 and Adf1 define Polycomb response elements (PRE) by interacting with Polycomb PRC1 component Pc (Orsi et al., 2014) . These findings inspired us to explore the possible interplay between 6mA and histone modifiers.
6mA is associated with the binding of Polycomb protein in Drosophila neuronal cells
To gain in-depth mechanistic insight into 6mA dynamics and gene regulation, we assessed the effects of reduced DMAD expression in a fly neuronal cell line, BG3C2 (Ui et al., 1994) , which was extensively analyzed in the modENCODE project. DMAD was knocked down (KD) using double-stranded RNA (dsRNAs), and successful KD was confirmed by qPCR and western blots (Figure 2A and 2B). Consistent with our data in fly brains, DMAD knockdown in BG3C2 neuronal cell line also led to an overall increase in 6mA levels ( Figure 2C ). A total of 6093 gain-of-6mA regions were identified in BG3C2 cells from replicates of control and DMAD-KD cells ( Figure S2A and Table S2 ). In parallel, RNA-seq analyses occurred for control and DMAD-KD BG3C2 cells (Table S2 ). Like our findings in the brain, gain-of-6mA regions were associated with intragenic regions such as introns and repetitive elements relative to expected values ( Figure S2B ). Also, GO analysis of downregulated genes containing intragenic gain-of-6mA regions showed preferential enrichment for neuronal functions ( Figure 2D ). Conversely, upregulated genes having gainof-6mA regions were enriched for general developmental pathways ( Figure S2C ). Furthermore, we found 42.5% and 21.2% of neuronally expressed Long interspersed elements (LINEs), and Long terminal repeats (LTRs) overlapped with gain-of-6mA regions ( Figure S2D ), consistent with the previous report that 6mA could potentially impact transposon expression (Zhang et al., 2015b) . To confirm the 6mA-IP seq data, we performed restriction enzyme digests to validate 6mA differential loci found by BG3C2 6mA-IP (Methods). As expected, the qPCR results were consistent with our 6mA-IP that these loci contain methylation on the adenines and 6mA accumulated upon DMAD-KD ( Figure S2E ).
To directly link 6mA to epigenetic modulators, we used ChIP-chip data available for BG3C2 cells from modENCODE (Ho et al., 2014) to investigate 6mA enrichment at epigenetic regulator binding sites. We calculated 6mA reads over non-enriched input at the epigenetic regulator binding sites, finding that 6mA is explicitly enriched at Polycomb protein binding sites, including Polycomb complex components Pc, dRING, Psc, and Ez, but not other epigenetic regulators such as HP1, Su(var)3-7 and CTCF ( Figure 2E and S2F). Moreover, knockdown of DMAD led to further 6mA accumulation primarily on Polycomb-binding sites ( Figure S2G ). Therefore, 6mA could potentially work cooperatively with Polycomb proteins to mediate epigenetic regulation of gene expression.
DMAD coordinates with Trithorax-related protein Wds to regulate gene expression by maintaining 6mA homeostasis at a group of neuronal genes
To investigate the regulatory roles of DMAD in gene expression, we performed ChIP-seq to map genome-wide DMAD binding sites in BG3C2 cells (Table S3 ). Genome-wide annotation of DMAD binding sites revealed its general intragenic enrichment, such as exons ( Figure S3A ). Interestingly, 6mA accumulated on introns and UTRs upon DMAD-KD ( Figure 3A ), consistent with genomic annotations of gain-of-6mA regions ( Fig. 1E ). We focused next on the DMAD-bound genes bearing accumulation of 6mA in their gene bodies in the DMAD-KD cells as they could be modulated by DMAD through 6mA demethylation. These genes were further separated into downregulated and upregulated genes ( Figure 3B and S3B). Interestingly, instead of more exon enrichment of general DMAD binding sites, DMAD showed more enrichment in introns of these genes, coinciding with 6mA accumulation in introns ( Figure 1E and S2B). These genes were subcategorized based on the DMAD intragenic binding regions ( Figure 3C and S3C). In general, DMAD binding sites and 6mA accumulation upon DMAD-KD were associated with the same genomic regions. For instance, a remarkable 95% and 98% of intronic 6mA accumulation were found in genes with DMAD binding to their introns, showing DMAD influenced these genes through their intronic 6mA demethylation ( Figure 3C and S3C). Interestingly, 76% of introns in downregulated genes harbored gain-of-6mA regions and DMAD binding sites in the exact intronic regions, further supporting that DMAD could demethylate 6mA in cis ( Figure 3D ).
Similar observations were also found in the upregulated genes, although the percentage of DMAD and gain-of-6mA binding to the same introns showed a lesser extent ( Figure S3D ). Given that DMAD depletion downregulated a group of critical neuronal genes, we hypothesized that DMAD may coordinate with transcriptional activators to maintain active expression profiles. Using the modENCODE ChIP-chip dataset, we found that binding sites of Wds (Will die slowly), a protein component of the Trithorax-related complex that is responsible for gene activation (Mohan et al., 2011) , substantially overlapped with DMAD binding sites ( Figure 3E ). This overlap appeared specific, as the binding sites of many other transcription factors available in ChIP-chip datasets did not overlap with DMAD ( Figure  S3E ). Wds is the Drosophila ortholog of the mammalian WDR5, and has been shown to modulate active transcription with other Trithorax components through histone modifications (Herz et al., 2012; Mohan et al., 2011) . Substantial overlap between Wds and DMAD binding sites suggested that Wds and DMAD may form a complex in vivo. To test this, we performed co-immunoprecipitation (co-IP) experiments and observed a biochemical association between DMAD and Wds in BG3C2 cells ( Figure 3F ). Altered genes in DMAD-KD BG3C2 cells significantly overlapped with differentially expressed genes due to the Wds knockdown ( Figure 3G and S3F). Interestingly, knockdown of Wds did not affect the global 6mA level, suggesting the DMAD target recognition and demethylation are independent of Wds ( Figure S3G and 3H ). Co-IP experiments using Wds and DMAD deletion constructs were performed to map their interaction domains. WD40 domains of Wds were critical for interaction with DMAD, as the complete removal of WD-40 domains abolished its binding to DMAD ( Figure S3I ). On the other hand, the C-terminal DMAD (aa 1657-2860) bearing the Tet-JBP catalytic domain, but not the DMAD N-terminal region (aa 1-1657) with the CXXC DNA-binding domain, was responsible for association with Wds ( Figure S3J ). Additional fine mapping revealed that DMAD 1657-2666, including the 6mA catalytic domain (aa 1796-2666), bind to Wds ( Figure S3K ). These data together suggest that the DMAD interaction with Wds is coupled with its 6mA demethylation activities.
Since ChIP-chip assays in general have lower resolution than ChIP-seq, we performed Wds ChIP-seq in control and DMAD-KD BG3C2 cells (Table S3 ). 2249 of 2976 Wds peaks overlapped with DMAD binding sites, actively supporting their cooperation in transcriptional control ( Figure 3H ). We further analyzed ChIP-seq data to understand the dynamic changes of Pc (Table S3 ) and Wds on DMAD binding sites and gain-of-6mA regions. We computed the normalized Pc, and Wds ChIP-seq reads ratios at DMAD binding sites using DMAD-KD over control cells. Wds, but not Pc, showed a significant reduction in the absence of DMAD ( Figure 3I , blue indicates KD reads < WT reads, p<0.001). Interestingly, substantial, and significant increases in Pc binding were found on gain-of-6mA regions, suggesting potential crosstalk between 6mA and Polycomb proteins ( Figure 3I , red indicates KD reads > WT reads, p<0.001). Using micrococcal nuclease (MNase) digestion coupled with high-throughput sequencing, we investigated the dynamic changes of nucleosome positioning on intragenic DMAD-binding sites and gain-of-6mA regions when DMAD was depleted. DMAD-binding sites showed no significant changes in nucleosome occupancy when DMAD was knocked down ( Figure S3L and S3N, p=0.4436). In contrast, gain-of-6mA regions displayed significantly higher nucleosome occupancy in DMAD-KD cells ( Figure S3M and S3O, p<0.0001), possibly due to Polycomb recruitment for chromatin remodeling (Orsi et al., 2014) . Our findings suggest that DMAD binds to specific sets of genes to modulate intragenic 6mA levels and coordinate with histone modifiers, thereby regulating gene expression.
6mA dynamic regulation by DMAD coordinates with Trithorax and Polycomb-mediated epigenetic mechanisms
To further define DMAD-mediated epigenetic regulatory mechanisms, we focused on two sets of regions located in downregulated genes that have vital neuronal functions: 1. Intragenic regions commonly bound by DMAD/Wds identified by ChIP-seq ( Figure 4A , green), and 2. Gain-of-6mA regions in intragenic regions of genes identified in Figure 4A that are also commonly bound by DMAD/Wds ( Figure 4B, pink) . We examined the dynamic changes of Pc and Wds binding as well as signature histone modifications, such as H3K27me3 and H3K4me3, at these loci in both control and DMAD-depleted cells. Intragenic regions bound by DMAD/Wds showed a slight but not significant reduction in Pc and H3K27me3 upon DMAD depletion. However, DMAD loss led to a substantial and significant reduction in Wds and the active histone marker H3K4me3 ( Figure 4A ). These data suggest that interplay between DMAD and Wds at these loci maintains transcriptional activation. We also noted that Wds was solely enriched at downregulated genes compared to non-enriched input ( Figure S3P and S3Q) . These data show that Wds, not Pc, is responsible for maintaining active expression of downregulated genes by interacting with DMAD. Genetic interaction between DMAD and Wds was further examined in the context of MB development. Either control (elav>+) or pan-neuronal knockdown of Wds alone (elav>Wds RNAi ) does not affect α lobe development. Pan-neuronal knockdown of DMAD (elav>DMAD RNAi ) causes α lobe defect that is significantly enhanced by the Wds knockdown (elav> Wds RNAi + DMAD RNAi ) ( Figure S3R ). These results further confirmed functional interplay between DMAD and Wds and suggested DMAD preceded and coordinated with Wds ( Figure S3R ). It also suggested that DMAD could partner with other Trithorax proteins in fly neurons. In agreement with this, Trithorax-related (Trr), a major H3K4 monomethyltransferase on enhancers, shared substantial overlap with DMAD (Herz et al., 2012) ( Figure S3S ).
Analysis of the second set of regions, which contain intragenic regions with increased 6mA upon DMAD-KD, show that Pc binding was concomitantly and significantly enhanced ( Figure 4B ). This observation supports the notion that accumulation of intragenic 6mA due to DMAD loss could facilitate Polycomb recruitment to secure transcriptional repression at these loci. In the absence of DMAD, these data suggest a dynamic switch between Trithorax and Polycomb proteins at these downregulated genes.
We also investigated upregulated genes bearing DMAD/Wds binding and gain-of-6mA regions. The DMAD-binding sites on these genes displayed a more sophisticated modulating network, showed by the co-occupancy of Wds and Pc on these regions ( Figure S3Q , S4A, and S4B). Importantly, Gene Ontology analyses showed a specific enrichment of neurodevelopment and neuronal functional terms of these downregulated genes bound by DMAD, compared to general terms of upregulated genes ( Figure S4C and S4D). This evidence implies that these downregulated genes could be the primary and direct targets of the DMAD-Wds complex related to neuronal development and functions.
To confirm the direct targets of DMAD and Wds, we independently knocked down DMAD, Wds, and Pc in BG3C2 cells. We also generated Pc/DMAD or Wds/DMAD double knockdown cell lines ( Figure S4E and S4F). Several loci shown in Figure 4A and 4B were tested for expression changes with these knockdown conditions. Similar genes were downregulated with either Wds knockdown or DMAD knockdown, supporting that Wds interacts and coordinates with DMAD to transcriptionally activate these genes. DMAD and Wds double knockdown showed synergistic effects on some loci. On the other hand, simultaneous depletion of DMAD and Pc sustained or stimulated gene expression, suggesting that Pc contributes to transcription repression ( Figure 4C and S4F ). However, we found the knockdown of Pc itself resulted in a significant reduction of Wds ( Figure S4E ). The reduction in Wds might represent interesting crosstalk between TrxG and PcG (Schuettengruber et al., 2007) . Considering this finding, we found that Pc knockdown resulted in reduced expression of some loci, possibly due to indirect effects of regulating Wds or other factor expression.
To obtain direct evidence that Pc preferentially binds to the 6mA mark, we synthesized DNA oligos with the gain-of-6mA/Pc common consensus sequence. The adenines in the consensuses sequence were either methylated or unmodified as a negative control. Control and 6mA-containing probes were used for in vitro binding with recombinant FLAG-Pc produced from baculovirus. We found that Pc preferentially binds to 6mA-modified probes over controls in vitro ( Figure 4D ). By using a Fluorescence-based DNA-binding assay (Hashimoto et al., 2014) , we calculated the binding kinetics. FLAG-Pc bound to probes in a dose-dependent manner, and 6mA-modified probes showed stronger binding kinetics (K d ) to Pc relative to control ( Figure 4E ).
We generated three Pc deletion constructs covering the chromodomain (Pc aa1-86), the linker region (Pc aa 75-228), and the cbox domain (Pc aa222-390) and tested their binding affinities to control and 6mA-modified DNA oligos ( Figure S4G and S4H) to define the 6mA-binding domain of Pc. Only the C-terminal Pc deletion (aa 222-390) bound to DNA probes and displayeda preference for 6mA-modified DNA probes, although with lower affinity than full-length Pc ( Figure S4I ). These data provide further evidence that 6mA has crosstalk with Polycomb proteins.
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METHOD DETAILS
DMAD-null and DMAD-KD fly lines
DMAD-null flies were described previously (Zhang et al., 2015b) . DMAD transgenic RNAi lines, P{uasp-2×artmiR-DMAD}, in which two sets of 71 nt oligos containing a small hairpin sequence targeting the DMAD coding region under the control of the uasp promoter, were generated according to the method described previously (Zhang et al., 2015b) . The sequences of these oligos are below. Immunostaining Fly brains were dissected in calcium-free 1x PBS and fixed in 4% paraformaldehyde for 1 hour on ice. Fixed tissues were permeabilized with 0.3% PTX (1x PBS + 0.3% Triton X-100) at room temperature for 30 minutes and then blocked in 0.1% PTX (1x PBS + 0.1% Triton X-100) + 5% Normal Goat Serum for 30 more minutes. Tissues were then incubated with anti-DMAD (1:200, Rb) or anti-6mA (1:500, Rb) in PBTG (PBST + 5% normal goat serum) overnight at 4ºC. Anti-Fasciclin II monoclonal antibody (DHSB, 1D4) was used to stain the Drosophila mushroom body. The next day, tissues were washed 3 times with 1x
PBST for 5 minutes and incubated with secondary antibody for 1 hour at room temperature. The tissues were washed 3 times with 1x PBST and mounted onto slides with Vectashield to prevent photobleaching. Samples were kept at −20ºC until observed under confocal microscopy.
Cell culture and RNAi
BG3C2 cells were cultured as described previously (Ui et al., 1994) . For double stranded RNA (dsRNA) knockdown, a 580bp dsRNA fragment targeting DMAD coding region was generated via T7 promoter-driven in vitro transcription using an RT-PCR product as template. The following primers were used for RT-PCR: forward −5'gaaatCTCGAGtaatacgactcactatagggCGGAGCCAGTAGTTTTCAGC3'and reverse −5'gaaatGAATTCtaatacgactcactatagggCATGGGGTTGATCTTCTCGT3'. The in vitro transcription was performed using HiScribe T7 High Yield RNA Synthesis Kit from NEB following manufacturer's instructions. dsRNA products were purified by two-step extractions with phenol: chloroform: isoamyl alcohol =25:24:1, followed by chloroform alone. The extracted dsRNA was precipitated with absolute ethanol. The dsRNA was incubated with BG3C2 cells that had been grown in Shields and Sang M3 insect medium under FBS starvation for at least 24 hours. After 24-hour incubation with dsRNA, FBS was added to the culture media to a final concentration of 3%. Fresh media containing dsRNA was replaced every 48 hours and the total incubation time was 144 hours to ensure effective knockdown.Drosophila S2 cells were cultured as described previously for coimmunoprecipitation experiments (Zhang et al., 2015a) .
Isolation of genomic DNA
Lysis buffer containing 100mM Tris-HCl (pH 8.5), 5mM EDTA (pH 8.0), 0.2% SDS, 200mM NaCl, and 20-25 l of protease K (20mg/ml) was added to homogenized tissues or cells, mixed well, and incubated at 55°C overnight. After the overnight digestion, the lysates were brought to room temperature, and incubated with 5 l of RNase A solution (20mg/ml) for at least 1 hour at room temperature. DNA was extracted by adding equal volume of phenol: chloroform: isoamyl alcohol at a ratio of 25:24:1 and centrifuged at 13,000 rpm for 10 minutes. Supernatant was transferred to clean tubes. Equal volume of isopropanol was then added to the supernatant and mixed well at room temperature to precipitate DNA. Once flocky DNA was visible, the precipitate was transferred to a new tube containing 1ml of 70% ethanol to wash. DNA was then collected by centrifugation and air dried.
UHPLC-MRM-MS/MS analysis
Genomic DNA was enzymatically digested into single nucleosides with a mixture of DNaseI, calf intestinal phosphatase, and snake venom phosphodiesterase I at 37°C for 12 h. After the enzymes were removed by ultrafiltration, the digested DNA was subjected to UHPLC-MS/MS analysis. HPLC fractionation of Drosophila m6dA and UHPLC-QTOF-MS/MS analysis were performed as described previously (Zhang et al., 2015b) .
Dot blot
Dot blot was performed as described previously (Szulwach et al., 2011) using 6mA rabbit polyclonal antibody. DNA samples were subjected to extensive RNase treatments before loading on Nitrocellulose membrane.
6mA Immunoprecipitation
Genomic DNA was sonicated to 200-300 bp fragments for 6mA enrichment using rabbit polyclonal antibody (Synaptic Systems) at 1:100 in 1x IP buffer containing 100mM Tris-HCl (pH7.4), 150mM NaCl and 0.05% Triton X-100. The DNA-antibody incubation was conducted on a rotating platform at 4°C overnight. Dynabeads Protein G (Novex by Life Technologies, REF 10009D 30mg/ml) were added the next day for additional 2 hours at 4°C. The beads were then washed six times at room temperature with 1x ice-cold IP buffer. After the wash, the immunoprecipitated DNA fragments were eluted by adding IP buffer containing 2.6mM 6mA for competitive elution. The elutions were repeated for three times at room temperature. The eluted DNA fragments were precipitated by isopropanol.
Chromatin Immunoprecipitation (ChIP)
BG3C2 cells (5-10 × 10 6 ) in the presence or absence of DMAD were fixed in 1% formaldehyde for 10 minutes at room temperature with gentle shaking, then 0.125 M final concentration of Glycine was added for additional 5-minute incubation to stop the fixation. Fixed cells were lysed on ice for 10 minutes in a NP-40 lysis buffer (10 mM Hepes/pH7.9, 0.5% NP-40, 1.5 mM MgCl 2 , 10 mM KCl, 0.5 mM DTT and protease inhibitor cocktail) to release nuclei. After centrifugation at 4000 rpm for 5 minutes, the nuclear pellets were further lysed by sonication on ice in a nuclear lysis buffer (20 mM Hepes/pH7.9, 25% glycerol, 0.5% NP-40, 0.5% Triton X-100, 0.42 M NaCl, 1.5 mM MgCl 2 , 0.2 mM EDTA and protease inhibitor cocktail), then centrifuged at 13,000 rpm for 10 minutes at 4°C. The supernatant was diluted with 2 volumes of dilution buffer (0.01% SDS, 1% Triton X-100, 1.2 mM EDTA, 167 mM NaCl, 16.7 mM Tris-HCl/pH8.0 and protease inhibitor cocktail). Immunoprecipitation was performed with desired antibodies for 6 hours to overnight at 4ºC. After antibody incubation, 20 l salmon sperm blocked DNA/protein G agarose (Upstate) were added and incubated for additional 1 hour. Precipitates were sequentially washed with TSE I (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 150 mM NaCl, 20 mM Tris-HCl/pH 8.0), TSE II (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 500 mM NaCl, 20 mM Tris-HCl/pH 8.0), TSE III (0.25 M LiCl, 1% NP-40, 1% deoxycholate, 1 mM EDTA, 10 mM Tris-HCl/pH 8.0), and then washed twice with TE buffer. The ChIP'ed DNA was eluted by elution buffer containing 1% SDS and 0.1 M NaHCO 3 . NaCl at final concentration of 0.2M was added to the elution along with 1 g RNaseA for reverse-crosslinking at 65 ºC for at least 6 hours. DNA fragments were purified using the PCR Purification Kit (Qiagen). ChIP'ed DNA was subjected to library preparation.
Co-Immunoprecipitation
BG3C2 or S2 cells were lysed for 10 minutes on ice with lysis buffer containing 25 mM Tris-HCl (pH7.5), 2mM MgCl 2 , 5mM DTT, 0.5%Triton-X100, and 300mM NaCl in the presence of DNase and RNase. The cell lysate was sonicated before centrifugation at maximum speed for 10 min; the supernatant was incubated with antibodies overnight at 4ºC. After antibody incubation, 20 l salmon sperm blocked DNA/protein G agarose beads (Upstate) were added and incubated for additional 1 hr. Beads were then washed 3 times by lysis buffer. The immunoprecipitated proteins were eluted with 2x Laemmli Sample Buffer (Bio-Rad) followed by western blots.
Baculovirus infection and FLAG-tagged Pc purification
SF9 cells were a gift from Dr. Xiaodong Cheng's lab in the Department of Biochemistry at the Emory University School of Medicine. SF9 cells were cultured in Sf-900™ III SFM media from Thermo Fisher Scientific, and infected with Baculovirus generated with pFastBac-FPC (full length Pc) with FLAG tag obtained from Addgene. Baculovirus were produced by LakePharma. 72-hour post infection, SF9 cells were collected and lysed in lysis buffer containing 25mM Tris-Cl (pH 7.5), 300mM NaCl, 0.5% Triton-X100, and protease inhibitor tablet (Roche) for 30 minutes on ice followed by sonication at 1.5V, 0-3W for 20 seconds. Samples with 300 l volume in each tube were sonicated 4 times. Lysate was centrifuged at 13,000 rpm for 10 minutes and supernatant was transferred to a new tube for IP purification. The supernatant was incubated with FLAG-M2 dynabeads (Sigma) and rotated at 4°C for 3 hours. Beads were then washed 5 times with 1x lysis buffer. To elute the FLAG-Pc, beads were incubated with the elution buffer containing 3X FLAG peptide at 100ug/ml for 2 hours at 4°C with gentle rotation. FLAG-Pc were tested by western blots.
Probe labeling and annealing
To compare Pc binding efficiency to 6mA DNA and unmodified DNA, two oligos were designed based on gain-of-6mA regions and the consensus sequence recognized by Pc (−5'-GAT CGA TCG A-CA CAC ACA CAC ACA CA-G ATC GAT CGA-3'). The forward and reverse oligos were separately labeled using the Biotin 3' End DNA Labeling Kit (Catalog number: 89818) from Pierce™Fisher Scientific per manufacturer's instruction. Labeled oligos were precipitated with 0.1 volume of 3M NaAc (pH 5.2) and 3 volumes of absolute ethanol. Precipitated oligos were dissolved in 50 l of nuclease free water and annealed into double stranded oligos.
Pc and DNA probe binding assays dsDNA probes with either unmodified A or 6mA were independently mobilized on Dynabeads Streptavidin MyOne C1 (Life Technologies) with 1x W/B buffer containing 25mM Tris-Cl (pH7.5), 1mM EDTA, and 1M NaCl at room temperature for 30 minutes with gentle rotation. The beads were then immobilized with probes and blocked with Blocker™ BSA (10x), Thermo Fisher Scientific (Catalog number: 37520) in TBS for 30 minutes at room temperature. Beads were washed twice with 1x lysis buffer. A range of purified FLAG-Pc protein concentrations (0.01 M to 1 M) was added to blocked beads and incubated for 1 hour at room temperature with gentle rotation. The beads were then washed extensively with 1x lysis buffer 5 times. FLAG-Pc was eluted in 2x Laemmli Sample Buffer (Bio-Rad) at 100°C for 10 minutes and loaded onto an SDS-polyacrylamide gel for Western blot to detect binding efficiency.
Generation of deletion/truncation constructs of DMAD, Wds and Pc
Site-directed mutagenesis kit (NEB) was used to generate series of deletion constructs from full length cDNA from DMAD, Wds and Pc. All constructs were subjected to Sanger sequencing to confirm the correct insertion. DMAD and Wds constructs were cloned into pAc 5.1 vector and expressed in Drosophila S2 cells for co-immunoprecipitation experiments. Pc deletion constructs were cloned into pFASTBAC plasmid for Baculovirus production (LakePharma).
Fluorescence-based Pc-6mA binding assays
The 6-carboxy-fluorescein (FAM)-labelled control or 6mA-modified DNA probes were annealed with their reverse complementary strand to form double-stranded DNA oligos. Various concentrations (0.01-1 M) of Pc full length or C-terminal truncation recombinant proteins were incubated with 2 nM DNA oligos for 15 minutes at room temperature in nicking buffer (10mM Tris-Cl pH8.0, 1mM EDTA, 0.1% BSA). Fluorescence polarization measurements were carried out at 25°C on a Synergy 4 microplate reader (BioTek). Curves were fit individually using GraphPad Prism 7.0 software (GraphPad Software, Inc.). Binding constants (K d ) were calculated described previously (Hashimoto et al., 2014) .
In vitro 6mA demethylation assay
Double stranded control and 6mA-modified DNA oligos were mixed with DMAD Cterminal catalytic domain (aa 1657-2860) in reaction buffer containing 50mM Hepes (pH8.0), 2mM ascorbate, 1mM a-KG and 150 mM Fe at room temperature for 3 hours. The reactions were stopped by proteinase K digestion at 50°C for 2 hours. The purified DNA samples were subjected to 6mA dot blots and ImageJ quantification.
DpnI digestion and qPCR
DpnI digestion and qPCR was conducted as previously described (Luo et al., 2016) . Briefly, restriction enzyme digestion was performed by treating 1 ug of genomic DNA with 5 uL of 5 U/uL DpnI restriction enzyme (NEB) at 37°C for 1 hour. The digested DNA and nondigested DNA (5 ng) were subjected to qPCR using FastStart SYBR Green Master kit. The restriction enzyme digestion method takes advantage of the 6mA-sensitive restriction enzyme DpnI that preferentially cleaves methylated adenine at GATC/CATC/GATG sites. Equal amounts of DpnI-digested DNA and undigested control DNA were subjected to qPCR analyses with primers targeting 6mA dynamic regions identified by 6mA-IP. The percentage of 6mA in either control or DMAD-KD can be assessed by qPCR amplification and normalized to undigested DNA control (digested/undigested). Loci with lower 6mA modification in controls would hinder DpnI digestion, resulting in higher PCR fold changes than DMAD-KD samples.
Library Preparation and High-throughput Sequencing
Enriched DNA from 6mA-IP and ChIP were subjected to library construction using the NEBNext ChIP-Seq Library Prep Reagent Set from Illumina according the manufacturer's protocol. Briefly, 25 ng of input genomic DNA or experimental enriched DNA were utilized for each library construction. DNA fragments (150-300 bp) were selected by AMPure XP Beads (Beckman Coulter) after adapter ligation. An Agilent 2100 BioAnalyzer was used to quantify amplified DNA and qPCR was applied to accurately quantify library concentration. 20 pM diluted libraries were used for sequencing. 50-cycle single-end sequencings were performed using Illumina HISeq 2000. Image processing and sequence extraction were done using the standard Illumina Pipeline. RNA-seq libraries were generated from duplicated samples per condition using the Illumina TruSeq RNA Sample Preparation Kit v2 following manufacturer's protocol. RNA-seq libraries were sequenced as 50-cycle pair-end runs using Illumina HISeq 2000.
Bioinformatics analyses
Bioinformatics analyses for ChIP-Seq and 6mA-IP-seq were conducted as described previously (Szulwach et al., 2011; Yao et al., 2014) . Briefly, FASTQ sequence files were aligned to the dm3 reference genome using Bowtie v1.1.2 (Langmead et al., 2009 ). Peaks were identified by Model-based Analysis of ChIP-Seq (MACS) software (Zhang et al., 2008) . Ngsplot software was used to calculate and plot unique 6mA and ChIP-Seq mapped reads various genomic regions and generated heatmaps (Shen et al., 2014) . Annotation and motif analysis were performed using the HOMER (Heinz et al., 2010) suite. RNA-seq reads were aligned using Tophat v2.0.8 (Trapnell et al., 2012) and differential RPKM expression values were extracted using cuffdiff v2.2.1 (Trapnell et al., 2012) . Genomic interval overlapping analyses were performed using Bedtools (Quinlan and Hall, 2010) . Gene Ontology analyses were performed by The Database for Annotation, Visualization and Integrated Discovery (DAVID) v6.7 (Huang da et al., 2009) and Gene Ontology Consortium (Ashburner et al., 2000) . Gain-of-6mA regions in BG3C2 cells were identified by published computational algorithm (R/Bioconductor package DSS) that implements a series of differential methylation detection algorithms based on the dispersion shrinkage method followed by Wald statistical test to rigorously interrogate the 6mA differential regions between replicated samples of control and DMAD-KD group (Feng et al., 2014) . Topranked gain-of-6mA regions were further intersected with 6mA peaks identified by MACS with FDR<0.05. modENCODE ChIP-chip regions were generated by CisGenome (Ji et al., 2006) . Transposon expression was analyzed by TEtranscripts (Jin et al., 2015) . Gain-of-6mA regions in brains were identified by bedtools (Quinlan and Hall, 2010) . MNase-seq data were analyzed using dynamic analysis of nucleosome position and occupancy by sequencing (DANPOS) (Chen et al., 2013) .
Sample size and Statistics
Fly brain RNA-seq experiments were performed using two control and DMAD-null pooled samples as biological replicates. Each pooled sample contained 500-1000 fly brains per sample per genotype. Fly brains were dissected from heads to avoid 6mA contamination from bacteria. BG3C2 RNA-seq samples were performed in triplicate from control and DMAD-KD cells. Brain RNA-seq were performed in duplicates. Differential expression analyses were performed by cuffdiff (Trapnell et al., 2012 
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Author Manuscript binding kinetics to control and 6mA-modified probes showed that Pc displayed stronger binding to 6mA-modified DNA probes, as measured by fluorescence polarization assays. (F) DMAD binds to a group of genes involved in neurodevelopment and neuronal functions. These genes are directly targeted by the Trithorax protein Wds to maintain an active transcription profile. Additionally, DMAD actively demethylates intragenic 6mA. In the absence of DMAD,Wds binding is reduced at these loci, and accumulation of intragenic 6mA recruits Polycomb proteins. Data are presented as mean ± SEM.
